Defendant

Anda

1 case as defendant.

Cases
1
Active
0
1 closed
Filed
2010
Top venue
D. New Jersey
1 case

Celgene Corporation v. Natco Pharma Ltd. et al.

settled
Docket:
2:10-cv-05197
Filed:
2010-10-08
Terminated:
2016-01-05
Patents:6561976

Celgene asserted US 6,561,976 as an asserted 'Celgene Patent' in an ANDA/Hatch-Waxman suit against Natco and others over generic THALOMID/REVLIMID. A May 7, 2014 stipulation recorded Natco's non-contest of infringement of certain claims of the ’976 patent. The case settled, and the docket terminated on Jan. 5, 2016.